Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2651 |
|
| Actual shortage: | 257 (10%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 9 (0%) | |
| Resolved: | 2385 (90%) | |
Discontinuation Reports |
250 |
|
| To be discontinued: | 3 (1%) | |
| Discontinued: | 247 (99%) | |
| Reversed: | 0 (0%) | |
Late reports |
329 (11%) |
|
Overdue reports |
26 (10%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-LISINOPRIL/HCTZ (TYPE Z) | 12.5MG 20MG | TABLET | Resolved | 2023-06-16 | 2023-08-04 | 195033 |
| TEVA-LISINOPRIL/HCTZ (TYPE Z) | 12.5MG 20MG | TABLET | Resolved | 2023-06-19 | 2023-07-14 | 195597 |
| TEVA-IRBESARTAN HCTZ | 12.5MG 300MG | TABLET | Resolved | 2017-05-10 | 2017-09-19 | 9785 |
| TEVA-IRBESARTAN HCTZ | 12.5MG 300MG | TABLET | Resolved | 2018-03-13 | 2018-05-30 | 42582 |
| TEVA-IRBESARTAN HCTZ | 12.5MG 300MG | TABLET | Resolved | 2018-12-04 | 2019-04-11 | 68622 |
| TEVA-IRBESARTAN HCTZ | 12.5MG 300MG | TABLET | Resolved | 2019-12-05 | 2021-09-10 | 100305 |
| TEVA-VALSARTAN/HCTZ | 12.5MG 320MG | TABLET | Resolved | 2017-04-25 | 2018-02-21 | 8074 |
| TEVA-VALSARTAN/HCTZ | 12.5MG 320MG | TABLET | Actual shortage | 2018-10-23 | 2019-07-15 | 65369 |
| TEVA-CANDESARTAN/HCTZ | 12.5MG 32MG | TABLET | Resolved | 2017-03-13 | 2017-10-10 | 974 |
| TEVA-CANDESARTAN/HCTZ | 12.5MG 32MG | TABLET | Resolved | 2019-11-28 | 2020-04-23 | 99932 |
| TEVA-CANDESARTAN/HCTZ | 12.5MG 32MG | TABLET | Resolved | 2022-10-28 | 2022-12-15 | 173031 |
| TEVA-CANDESARTAN/HCTZ | 12.5MG 32MG | TABLET | Resolved | 2023-10-05 | 2024-04-05 | 206425 |
| TEVA-OLMESARTAN / HCTZ | 12.5MG 40MG | TABLET | Resolved | 2018-09-12 | 2020-06-11 | 61359 |
| TEVA-CILAZAPRIL/HCTZ | 12.5MG 5MG | TABLET | Resolved | 2019-06-18 | 2019-08-06 | 86975 |
| TEVA-TELMISARTAN HCTZ | 12.5MG 80MG | TABLET | Resolved | 2017-04-03 | 2017-09-19 | 5229 |
| TEVA-TELMISARTAN HCTZ | 12.5MG 80MG | TABLET | Resolved | 2018-11-20 | 2019-04-27 | 67234 |
| TEVA-TELMISARTAN HCTZ | 12.5MG 80MG | TABLET | Resolved | 2018-11-20 | 2019-07-15 | 67237 |
| TEVA-TELMISARTAN HCTZ | 12.5MG 80MG | TABLET | Resolved | 2018-11-20 | 2019-04-27 | 67240 |
| TEVA-TELMISARTAN HCTZ | 12.5MG 80MG | TABLET | Resolved | 2019-08-22 | 2022-01-07 | 92195 |
| TEVA-VALSARTAN/HCTZ | 12.5MG 80MG | TABLET | Actual shortage | 2019-09-26 | 2021-04-22 | 94834 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| DOCETAXEL INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63937 | ||
| DOCETAXEL INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63940 | ||
| TEVA-CIPROFLOXACIN | Discontinued | 2018-10-12 | 2018-10-12 | 63952 | ||
| GEMCITABINE FOR INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63967 | ||
| GEMCITABINE FOR INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63970 | ||
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64520 | ||
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64526 | ||
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64529 | ||
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64532 | ||
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64535 | ||
| TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64544 | ||
| TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64547 | ||
| TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64550 | ||
| TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64553 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64589 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64592 | ||
| RATIO-MEMANTINE | Discontinued | 2018-10-17 | 2018-10-17 | 64595 | ||
| RATIO-MEMANTINE | Discontinued | 2018-10-17 | 2018-10-17 | 64598 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64615 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64623 |